Abattis Bioceuticals Corp.

CNSX : FLU


Abattis Bioceuticals Corp.

October 19, 2012 18:56 ET

Abattis Announces Resignation of a Director

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 19, 2012) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX:FLU) announces the resignation of Mr. Yazan Al Homsi as a Director of the Company effective October 19, 2012. Mr. Mike Withrow, Chairman of the Board of the Directors on behalf of the Company, thanks Mr. Al Homsi for his service and contribution to the Company.

About Abattis Bioceuticals Corp.

Abattis Bioceutical Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients for use in BioPharma, Nutraceutical, Cosmetic and Animal Nutrition markets. The company has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at www.abattis.com.

ON BEHALF OF THE BOARD

Michael Withrow, President & CEO

Neither the CNSX Exchange nor its regulations services accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Abattis Bioceuticals Corp.
    Michael Withrow
    President & CEO
    778-710-9248
    604-538-6658 (FAX)
    www.abattis.com